Literature DB >> 11900990

Chemokines in cancer.

Alain P Vicari1, Christophe Caux.   

Abstract

Chemokines participate, by regulating cell trafficking and controlling angiogenesis, in the host response during infection and inflammation. Most of these mechanisms are also operating in cancer. The stimulation of angiogenesis and tumor growth--directly or indirectly through the recruitment of tumor-associated macrophages--are typical situations where chemokines promote tumor development. On the other hand, chemokines could be used to the benefit of cancer patients as they act in the recruitment of dendritic cells (DC) or/and effector cells or for their angiostatic properties. However, chemokine-mediated recruitment of immature DC within tumors, due to factors produced by the tumor milieu, could lead to the induction of immune tolerance and, therefore, novel strategies to eradicate tumors based on chemokines should attempt to avoid this risk.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900990     DOI: 10.1016/s1359-6101(01)00033-8

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  93 in total

1.  CD192 gene variant and susceptibility to cervical cancer: a meta analysis.

Authors:  Yuying Chen; Xinli Liu; Min Chen; Jian Shen; Yanqi Lu; Lei Yu; Shouying Liu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis of laryngeal squamous cell carcinoma.

Authors:  Liang Han; Bin Jiang; Hao Wu; Xudong Wang; Xiaojun Tang; Jianfei Huang; Jin Zhu
Journal:  Med Oncol       Date:  2012-01-25       Impact factor: 3.064

3.  Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces human CC- and CXC-chemokines in vitro and in vivo.

Authors:  Y Luo; X Chen; M A O'Donnell
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

4.  Tumor interstitial fluid and postoperative recurrence of tumors: An experimental study for verifying hypothesis of "tumor-phlegm microenvironment".

Authors:  Da-zhi Sun; Da-wei Ju; Jin He; Ye Lu; Feng Wu; Chang Li; Pin-kang Wei
Journal:  Chin J Integr Med       Date:  2010-09-25       Impact factor: 1.978

Review 5.  CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.

Authors:  Hyo Jin Lee; Ik-Chan Song; Hwan-Jung Yun; Deog-Yeon Jo; Samyong Kim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

6.  Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.

Authors:  Samuel Kim; George Buchlis; Zvi G Fridlender; Jing Sun; Veena Kapoor; Guanjun Cheng; Andrew Haas; Hung Kam Cheung; Xiamei Zhang; Michael Corbley; Larry R Kaiser; Leona Ling; Steven M Albelda
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

7.  Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment.

Authors:  Sharon Wei Ling Lee; R J Seager; Felix Litvak; Fabian Spill; Je Lin Sieow; Penny Hweixian Leong; Dillip Kumar; Alrina Shin Min Tan; Siew Cheng Wong; Giulia Adriani; Muhammad Hamid Zaman; And Roger D Kamm
Journal:  Integr Biol (Camb)       Date:  2020-04-20       Impact factor: 2.192

8.  Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis.

Authors:  Pierre Nahon; Angela Sutton; Pierre Rufat; Chantal Simon; Jean-Claude Trinchet; Liliane Gattegno; Michel Beaugrand; Nathalie Charnaux
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

9.  64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4.

Authors:  Orit Jacobson; Ido D Weiss; Lawrence Szajek; Joshua M Farber; Dale O Kiesewetter
Journal:  Bioorg Med Chem       Date:  2009-01-15       Impact factor: 3.641

10.  PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells.

Authors:  Christelle P El Haibi; Praveen K Sharma; Rajesh Singh; Paul R Johnson; Jill Suttles; Shailesh Singh; James W Lillard
Journal:  Mol Cancer       Date:  2010-04-22       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.